FDA Official: Make Minutes From FDA, Sponsor Meetings Public

Drug Industry Daily
A A
CDER should be allowed to release minutes from its meetings with sponsors so that a more accurate account of the interactions is made public and the FDA can defend itself against accusations that it shifted its expectations during reviews, an FDA official says.

To View This Article:

Login

Subscribe To Drug Industry Daily